Federal grants to Vesicle Therapeutics Inc
Vesicle Therapeutics Inc in Longmont, Colorado received $1.1 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Cardiovascular Diseases Research, with $744,668. In fiscal 2025 it was awarded $400,000.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$1.1 million
- Awards3
- Awarded in FY 2025$400,000
- Largest award$427,845
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 2 | $744,668 |
| FY 2023 | 0 | $0 |
| FY 2024 | 0 | $0 |
| FY 2025 | 1 | $400,000 |
Programs that fund Vesicle Therapeutics Inc
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 2 | $744,668 |
| Cancer Treatment Research | 1 | $400,000 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $1.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Targeting GPR146 for the treatment of homozygous familial hypercholesterolemia - project summary vesicle therapeutics inc aims to develop and commercialize a new therapy for homozygous familial hypercholesterolemia (HOFH). A majority of hofh is caused by mutations in both alleles of the gene encodin | Cardiovascular Diseases Research | April 15, 2022 | $427,845 |
| Targeting STAT3 with novel thiomorpholino antisense oligonucleotides for cancer therapy - project summary vesicle therapeutics, inc. (VTI) is developing a targeted antisense oligonucleotide (ASO) using innovative thiomorpholino chemistry (TMO) to treat head and neck cancer, particularly squamous cel | Cancer Treatment Research | September 15, 2025 | $400,000 |
| Development of a gectosome therapy for cardiovascular diseases - project summary vesicle therapeutics inc aims to develop and commercialize a new therapy for homozygous familial hypercholesterolemia (HOFH). A majority of hofh is caused by mutations in both alleles of the gene encoding the ldl recept | Cardiovascular Diseases Research | December 20, 2021 | $316,823 |
Questions people ask
How much federal grant money does Vesicle Therapeutics Inc get?
$1.1 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Vesicle Therapeutics Inc the most?
The Department of Health and Human Services, with $1.1 million in 3 awards.
What is Vesicle Therapeutics Inc's largest federal grant?
$427,845 under Cardiovascular Diseases Research, with its first action in the period on April 15, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Vesicle Therapeutics Inc?
Its largest are Cardiovascular Diseases Research and Cancer Treatment Research.
Other grant recipients in Longmont
- Oweesta Corp
- First Nations Development Institute
- Wild Plum Center for Young Children and Families, Inc.
- City of Longmont
- Honeybee Robotics LLC
- Meadowlark Optics, Inc.
- Kromatid, Inc.
- Amicus O & M Cooperative
Largest federal grant recipients in Colorado · Federal grants in Colorado